TB Deaths Hit Record Low, But Progress Under Threat Due to Funding Shortfalls
According to a report published by the World Health Organization (WHO), tuberculosis claimed the lives of approximately 1.23 million people in 2024, a decline of three percent from the previous year. This represents the first time since the COVID-19 pandemic that TB cases and deaths have decreased.
The WHO also reported a two percent drop in TB cases globally, with nearly eight million new patients seeking treatment for the disease last year. Treatment success rates rose to 71%, up from 68% in 2023.
However, despite these positive trends, the WHO warned that recent progress in tackling TB is at risk due to significant funding shortfalls. The agency has struggled to meet its annual target of $22 billion by 2027, with only $5.9 billion available for prevention, diagnosis, and treatment last year.
According to WHO chief Tedros Adhanom Ghebreyesus, the shortfall in aid could "reverse the hard-won gains" made in reducing TB cases and deaths. The agency's director of tuberculosis, HIV, and related infections, Tereza Kasaeva, warned that long-term cuts in international donor funding could lead to up to 2 million additional deaths and 10 million people falling ill with TB between 2025 and 2035.
The US Agency for International Development has also been significantly impacted by the withdrawal of the United States from the WHO, forcing a 21% cut to its proposed spending. This move has raised concerns about global TB treatment and access to life-saving services.
According to a report published by the World Health Organization (WHO), tuberculosis claimed the lives of approximately 1.23 million people in 2024, a decline of three percent from the previous year. This represents the first time since the COVID-19 pandemic that TB cases and deaths have decreased.
The WHO also reported a two percent drop in TB cases globally, with nearly eight million new patients seeking treatment for the disease last year. Treatment success rates rose to 71%, up from 68% in 2023.
However, despite these positive trends, the WHO warned that recent progress in tackling TB is at risk due to significant funding shortfalls. The agency has struggled to meet its annual target of $22 billion by 2027, with only $5.9 billion available for prevention, diagnosis, and treatment last year.
According to WHO chief Tedros Adhanom Ghebreyesus, the shortfall in aid could "reverse the hard-won gains" made in reducing TB cases and deaths. The agency's director of tuberculosis, HIV, and related infections, Tereza Kasaeva, warned that long-term cuts in international donor funding could lead to up to 2 million additional deaths and 10 million people falling ill with TB between 2025 and 2035.
The US Agency for International Development has also been significantly impacted by the withdrawal of the United States from the WHO, forcing a 21% cut to its proposed spending. This move has raised concerns about global TB treatment and access to life-saving services.